With elevated neo-antigen expression levels and high immune evasion of tumor cells, lung cancer presents an ideal setting for the expression of programmed cell death-1 (PD-1), programmed death-ligand 1 (PD-L1), and Cytotoxic-T-lymphocyte-antigen-4 (CTLA-4). This evidence concerns the gene PDCD1 and lung carcinoma.